StrideBio, Inc logo

StrideBio, Inc

The next evolution in gene therapy

4 employees · est. 2015 · Durham, United States

VS
VectorY logo

VectorY

VectorY combines the therapeutic potential of antibodies and gene therapy to develop long-lasting therapeutic solutions.

109 employees · est. 2020 · Amsterdam, The Netherlands

StrideBio, Inc is the older company (2015 vs 2020); VectorY is the larger of the two.

Side-by-Side Comparison

StrideBio, Inc VectorY
Founded
2015 older 2020
Headquarters
Durham, United States Amsterdam, The Netherlands
Employees
4 109 larger
Industry
Biotechnology, Health Care, Health and Wellness Biotechnology
Funding Stage
Acquired Series A
Total Funding
$97.20M $160.00M
Funding Rounds
5 2
Services
Development of gene therapies, AAV (Adeno-associated virus) manufacturing, Drug development for life-threatening diseases Not tracked yet
Target Customers
Patients with life-threatening diseases, Healthcare providers, Biopharmaceutical sector Not tracked yet
Taxonomy
Gene Therapy, AAV Vectors, Genetic Medicines, Rare Diseases, Vector Engineering, Pre-existing Neutralizing Antibody Evasion, Tissue Targeting, Potency Enhancement, Manufacturability, In-house Manufacturing, Gene Construct Design, Innovative Healthcare Solutions, Therapeutics Development, Biopharmaceuticals Gene Therapy, Antibody Therapy, Vectorized Antibodies, CNS Disorders, Somatic Disorders, Muscle Diseases, AAV-based Vector Technology, Therapeutic Development, Biopharmaceutical Manufacturing, Suspension-based Viral Vector Manufacturing, GMP Facility, Innovative Therapeutics, R&D
Website
stridebio.com vectorytx.com
StrideBio, Inc logo

About StrideBio, Inc

StrideBio, Inc, founded in 2015, is a pioneering gene therapy company headquartered in the United States. Their slogan, "The next evolution in gene therapy," underscores their commitment to developing transformative genetic medicines. StrideBio's innovative approach addresses the challenges of first...

VectorY logo

About VectorY

VectorY is a promising player in the Biotechnology industry, leveraging the therapeutic potential of antibodies and gene therapy to address large disease areas with high unmet medical needs. Founded in August 2020 and based in the Amsterdam Science Park, this fully integrated gene therapy company is...

We will tell you when either one moves

BounceWatch watches StrideBio, Inc and VectorY for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at StrideBio, Inc and VectorY — by email.

Frequently Asked Questions

StrideBio, Inc — The next evolution in gene therapy. VectorY — VectorY combines the therapeutic potential of antibodies and gene therapy to develop long-lasting therapeutic solutions.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
StrideBio, Inc has raised $97.20M while VectorY has raised $160.00M.
StrideBio, Inc and VectorY operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare StrideBio, Inc with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at StrideBio, Inc on 15 Jun 2026, and VectorY on 22 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy